Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease
- PMID: 16119705
- DOI: 10.1038/ncpcardio0270
Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease
Abstract
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with a strong female predilection. Cardiovascular morbidity and mortality is a frequent complication, particularly in females aged 35-44 years, in whom the risk of myocardial infarction is raised 50-fold. The mechanisms underlying this increased risk are not fully understood. Certain traditional risk factors, such as hypertension and diabetes mellitus, are more common in SLE patients than in the general population. These factors do not, however, completely account for the increased cardiovascular risk; factors such as renal impairment, increased homocysteine levels and early menopause probably have a role. In addition, several factors more specifically related to lupus are proposed to be of importance, including chronic inflammation, antiphospholipid antibodies and therapy, especially corticosteroid use. Thus, we need to be proactive in our approach to risk-factor management in SLE patients. Here, we propose that, like diabetes mellitus, SLE should be considered a coronary heart disease equivalent condition for baseline risk and that assessment of cardiovascular risk should be done routinely. In addition to lifestyle modifications, blood pressure and cholesterol levels should be stringently controlled, and administration of aspirin should be considered in selected patients. The increased use of certain interventions, such as statins, also needs to be more widely investigated in this population.
Similar articles
-
[Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].Minerva Med. 2003 Apr;94(2):63-70. Minerva Med. 2003. PMID: 12858154 Review. Italian.
-
'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.Rheumatology (Oxford). 2005 Dec;44(12):1492-502. doi: 10.1093/rheumatology/kei142. Epub 2005 Oct 18. Rheumatology (Oxford). 2005. PMID: 16234277 Review.
-
[Atherosclerosis in systemic lupus erythematosus].Presse Med. 2014 Oct;43(10 Pt 1):1034-47. doi: 10.1016/j.lpm.2014.01.021. Epub 2014 Sep 5. Presse Med. 2014. PMID: 25201598 Review. French.
-
Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients.Clin Rheumatol. 2007 May;26(5):695-9. doi: 10.1007/s10067-006-0376-1. Epub 2006 Aug 15. Clin Rheumatol. 2007. PMID: 16909327
-
Risk factors in cardiovascular disease in systemic lupus erythematosus.Curr Cardiol Rev. 2013 Feb 1;9(1):15-9. doi: 10.2174/157340313805076304. Curr Cardiol Rev. 2013. PMID: 23463953 Free PMC article. Review.
Cited by
-
Rare diagnosis of coexistent antiphospholipid syndrome and systemic lupus erythematosus in a male patient with successful management: a case report.Ann Med Surg (Lond). 2023 Apr 6;85(5):1983-1986. doi: 10.1097/MS9.0000000000000556. eCollection 2023 May. Ann Med Surg (Lond). 2023. PMID: 37228943 Free PMC article.
-
Cardiovascular disease in systemic lupus erythematosus.Rheumatol Immunol Res. 2021 Dec 15;2(3):157-172. doi: 10.2478/rir-2021-0022. eCollection 2021 Sep 1. Rheumatol Immunol Res. 2021. PMID: 35880242 Free PMC article. Review.
-
Peak strain dispersion within the left ventricle detected by two-dimensional speckle tracking in patients with uncomplicated systemic lupus erythematosus.Int J Cardiovasc Imaging. 2021 Jul;37(7):2197-2205. doi: 10.1007/s10554-021-02201-7. Epub 2021 Mar 4. Int J Cardiovasc Imaging. 2021. PMID: 33661409
-
Pathological manifestation of autoimmune myocarditis is detected prior to glomerulonephritis in a murine model of lupus nephritis.Lupus. 2020 Nov;29(13):1790-1799. doi: 10.1177/0961203320948959. Epub 2020 Oct 12. Lupus. 2020. PMID: 33045900 Free PMC article.
-
Potential Roles of Antiphospholipid Antibodies in Generating Platelet-C4d in Systemic Lupus Erythematosus.Antibodies (Basel). 2017 Jul 2;6(3):9. doi: 10.3390/antib6030009. Antibodies (Basel). 2017. PMID: 31548524 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical